REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 83 filers reported holding REPROS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $970,000 | -19.9% | 1,001,000 | 0.0% | 0.21% | -8.9% |
| Q4 2015 | $1,211,000 | -85.6% | 1,001,000 | -11.6% | 0.24% | -88.7% |
| Q3 2015 | $8,413,000 | +3.9% | 1,132,367 | 0.0% | 2.08% | +11.5% |
| Q2 2015 | $8,096,000 | -16.8% | 1,132,367 | 0.0% | 1.86% | -9.2% |
| Q1 2015 | $9,727,000 | -13.8% | 1,132,367 | 0.0% | 2.05% | -48.6% |
| Q4 2014 | $11,290,000 | +0.7% | 1,132,367 | 0.0% | 4.00% | -7.7% |
| Q3 2014 | $11,210,000 | -35.4% | 1,132,367 | +12.9% | 4.33% | -26.7% |
| Q2 2014 | $17,358,000 | +74.5% | 1,003,367 | +79.0% | 5.90% | +72.4% |
| Q1 2014 | $9,945,000 | +18.3% | 560,600 | +22.0% | 3.42% | +8.7% |
| Q4 2013 | $8,409,000 | – | 459,508 | – | 3.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,210,000 | 4.33% |
| DESTRIER CAPITAL MANAGEMENT LLC | 933,600 | $9,243,000 | 2.32% |
| SENZAR ASSET MANAGEMENT, LLC | 753,600 | $7,460,000 | 2.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,014,164 | $10,040,000 | 1.39% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 775,307 | $7,675,000 | 0.50% |
| Trellus Management Company, LLC | 50,000 | $495,000 | 0.42% |
| FNY Managed Accounts LLC | 14,000 | $138,600,000 | 0.42% |
| GENERAL AMERICAN INVESTORS CO INC | 449,475 | $4,450,000 | 0.36% |
| Baker Brothers Advisors | 2,778,654 | $27,509,000 | 0.35% |
| CQS Cayman LP | 550,000 | $5,445,000 | 0.32% |